Organigram Leverages FAST™ Tech for SHRED Shotz Beverage Launch

  • Organigram Global is launching SHRED Shotz, a 65ml cannabis beverage utilizing its FAST™ nanoemulsion technology.
  • SHRED, the brand underpinning the new product, generated $200 million in retail sales in 2025.
  • FAST™ technology, developed in collaboration with BAT, reportedly delivers up to 50% faster onset and improved bioavailability.
  • SHRED Shotz will initially be available in Ontario and Atlantic Canada in March 2026, with 10mg THC per serving.

Organigram's move to leverage its FAST™ technology and established SHRED brand demonstrates a strategic focus on product differentiation within the increasingly competitive Canadian cannabis market. The launch aims to capture a broader consumer base through a convenient, fast-acting format, but also introduces potential regulatory and consumer perception risks associated with rapid-onset cannabis products. Organigram’s partnership with BAT for FAST™ technology represents a significant bet on ingestible cannabis innovation.

Market Adoption
The success of SHRED Shotz will hinge on consumer acceptance of the compact format and faster-onset delivery, potentially attracting new users to the cannabis beverage category.
FAST™ Performance
Continued clinical validation and demonstrable advantages of the FAST™ technology will be crucial for Organigram to justify its investment and potentially license it to other players.
Regulatory Scrutiny
The rapid onset of SHRED Shotz may draw increased scrutiny from Health Canada regarding consumer safety and product labeling, potentially impacting future product development and market access.